LFCR(Lifecore Biomedical, Inc.) 的财务报表:医疗保健,特药与仿制药。数据来自 SEC 公开申报与市场行情,不构成投资建议。
| 科目 | FY 截至 2021-05-30 | FY 截至 2022-05-29 | FY 截至 2023-05-28 | FY 截至 2024-05-26 | FY 截至 2025-05-25 |
|---|---|---|---|---|---|
| 营业收入 | $100.87M | $111.27M | $103.27M | $128.26M | $128.87M |
| 毛利润 | $38.94M | $39.07M | $27.98M | $41.85M | $40.30M |
| 营业利润 | −$8.82M | −$11.79M | −$21.80M | −$8.84M | −$17.25M |
| 净利润 | −$32.29M | −$116.72M | −$99.56M | $12.01M | −$38.72M |
| 经营现金流 | $16.47M | −$22.59M | −$17.44M | $257.00K | −$206.00K |
| 自由现金流 | −$2.79M | −$48.82M | — | −$18.14M | −$13.62M |
| 摊薄每股收益 | $-1.10 | $-3.97 | $-3.32 | $0.33 | $-1.27 |